JP2023514333A5 - - Google Patents
Info
- Publication number
- JP2023514333A5 JP2023514333A5 JP2022549496A JP2022549496A JP2023514333A5 JP 2023514333 A5 JP2023514333 A5 JP 2023514333A5 JP 2022549496 A JP2022549496 A JP 2022549496A JP 2022549496 A JP2022549496 A JP 2022549496A JP 2023514333 A5 JP2023514333 A5 JP 2023514333A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025207474A JP2026049728A (ja) | 2020-02-18 | 2025-11-28 | Ｐｓｍａ発現がんを処置する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977932P | 2020-02-18 | 2020-02-18 | |
| US62/977,932 | 2020-02-18 | ||
| PCT/US2021/018447 WO2021168028A1 (en) | 2020-02-18 | 2021-02-18 | Method of treating psma-expressing cancers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025207474A Division JP2026049728A (ja) | 2020-02-18 | 2025-11-28 | Ｐｓｍａ発現がんを処置する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514333A JP2023514333A (ja) | 2023-04-05 |
| JP2023514333A5 true JP2023514333A5 (https=) | 2024-02-26 |
| JPWO2021168028A5 JPWO2021168028A5 (https=) | 2024-02-26 |
Family
ID=77391664
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549496A Pending JP2023514333A (ja) | 2020-02-18 | 2021-02-18 | Ｐｓｍａ発現がんを処置する方法 |
| JP2025207474A Pending JP2026049728A (ja) | 2020-02-18 | 2025-11-28 | Ｐｓｍａ発現がんを処置する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025207474A Pending JP2026049728A (ja) | 2020-02-18 | 2025-11-28 | Ｐｓｍａ発現がんを処置する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230098279A1 (https=) |
| EP (1) | EP4107279A4 (https=) |
| JP (2) | JP2023514333A (https=) |
| CN (1) | CN115380117A (https=) |
| WO (1) | WO2021168028A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016010927A2 (pt) | 2013-11-14 | 2017-08-08 | Endocyte Inc | Conjugado de fórmula |
| US12208102B2 (en) | 2018-04-17 | 2025-01-28 | Endocyte, Inc. | Methods of treating cancer |
| CN114096264B (zh) | 2019-05-20 | 2025-03-14 | 因多塞特股份有限公司 | 制备psma缀合物的方法 |
| CN118852044A (zh) | 2021-09-03 | 2024-10-29 | 晶核生物医药科技(南京)有限公司 | 一种肽脲素衍生物、含其的药物组合物及其应用 |
| WO2026002208A1 (zh) * | 2024-06-28 | 2026-01-02 | 思路迪生物医药(上海)有限公司 | 前列腺特异性膜抗原小分子抑制剂及其放射性核素配合物的制备及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4095130T (lt) * | 2013-10-18 | 2024-04-25 | Novartis Ag | Žymėti prostatos specifinio membranos antigeno (psma) inhibitoriai, jų naudojimas kaip vizualizavimo medžiagų ir farmacinių medžiagų prostatos vėžiui gydyti |
| US20150110814A1 (en) * | 2013-10-18 | 2015-04-23 | Psma Development Company, Llc | Combination therapies with psma ligand conjugates |
| US10688200B2 (en) * | 2015-12-31 | 2020-06-23 | Five Eleven Pharma Inc. | Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy |
| EP3607319A1 (en) * | 2017-04-07 | 2020-02-12 | Juno Therapeutics, Inc. | Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods |
| TW201922291A (zh) * | 2017-11-16 | 2019-06-16 | 瑞士商諾華公司 | 組合療法 |
| SG11202005511VA (en) * | 2017-12-13 | 2020-07-29 | Sciencons AS | Complex comprising a psma-targeting compound linked to a lead or thorium radionuclide |
| US12208102B2 (en) * | 2018-04-17 | 2025-01-28 | Endocyte, Inc. | Methods of treating cancer |
| WO2019246514A1 (en) * | 2018-06-21 | 2019-12-26 | Regeneron Pharmaceuticals, Inc. | Bispecific anti-psma x anti-cd28 antibodies and uses thereof |
-
2021
- 2021-02-18 EP EP21757774.1A patent/EP4107279A4/en active Pending
- 2021-02-18 US US17/904,442 patent/US20230098279A1/en active Pending
- 2021-02-18 WO PCT/US2021/018447 patent/WO2021168028A1/en not_active Ceased
- 2021-02-18 CN CN202180029214.XA patent/CN115380117A/zh active Pending
- 2021-02-18 JP JP2022549496A patent/JP2023514333A/ja active Pending
-
2025
- 2025-11-28 JP JP2025207474A patent/JP2026049728A/ja active Pending